Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stevens

Showing results (211-220 of 295) with videos related to

Pageof 30
Sort By:
Clinical and Experimental Rheumatology|October 3, 2018
The role of inflammatory markers in assessment of disease activity in systemic sclerosisLaura Ross, Wendy Stevens, Candice Rabusa, et al.
Arthritis Care & Research|September 4, 2024
Comparison of Three Physician Global Assessment Instruments in Systemic SclerosisLaura Ross, Dylan Hansen, Susanna Proudman, et al.
Southern African Journal of Infectious Diseases|October 8, 2024
Validation of Roche immunoassay for severe acute respiratory coronavirus 2 in South AfricaJurette S Grove, Elizabeth S Mayne, Wendy A Burgers, et al.
Plos One|February 4, 2022
Performance of the Abbott SARS-CoV-2 IgG serological assay in South African 2 patientsSarika Jugwanth, Maemu P Gededzha, Nakampe Mampeule, et al.
Clinical and Experimental Rheumatology|May 24, 2016
The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Arthritis Research & Therapy|November 20, 2013
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Seminars in Arthritis and Rheumatism|April 17, 2024
Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Canadian Respiratory Journal|November 12, 2025
Impact of Comorbidities on Treatments and Outcomes of Systemic Sclerosis-Associated Pulmonary Arterial HypertensionLisa Lim, Dylan Hansen, Jessica Fairley, et al.
Internal Medicine Journal|September 29, 2023
Multidisciplinary team discussion: the emerging gold standard for management of cardiopulmonary complications of connective tissue diseaseJessica L Fairley, Laura Ross, Andrew Burns, et al.
Arthritis Research & Therapy|May 12, 2023
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosisJessica L Fairley, Dylan Hansen, Laura Ross, et al.
Pageof 30

Showing results (211-220 of 295) with videos related to

Sort By:
Pageof 30
Clinical and Experimental Rheumatology|October 3, 2018
The role of inflammatory markers in assessment of disease activity in systemic sclerosisLaura Ross, Wendy Stevens, Candice Rabusa, et al.
Arthritis Care & Research|September 4, 2024
Comparison of Three Physician Global Assessment Instruments in Systemic SclerosisLaura Ross, Dylan Hansen, Susanna Proudman, et al.
Southern African Journal of Infectious Diseases|October 8, 2024
Validation of Roche immunoassay for severe acute respiratory coronavirus 2 in South AfricaJurette S Grove, Elizabeth S Mayne, Wendy A Burgers, et al.
Plos One|February 4, 2022
Performance of the Abbott SARS-CoV-2 IgG serological assay in South African 2 patientsSarika Jugwanth, Maemu P Gededzha, Nakampe Mampeule, et al.
Clinical and Experimental Rheumatology|May 24, 2016
The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Arthritis Research & Therapy|November 20, 2013
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Seminars in Arthritis and Rheumatism|April 17, 2024
Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Canadian Respiratory Journal|November 12, 2025
Impact of Comorbidities on Treatments and Outcomes of Systemic Sclerosis-Associated Pulmonary Arterial HypertensionLisa Lim, Dylan Hansen, Jessica Fairley, et al.
Internal Medicine Journal|September 29, 2023
Multidisciplinary team discussion: the emerging gold standard for management of cardiopulmonary complications of connective tissue diseaseJessica L Fairley, Laura Ross, Andrew Burns, et al.
Arthritis Research & Therapy|May 12, 2023
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosisJessica L Fairley, Dylan Hansen, Laura Ross, et al.
Pageof 30